Tag: Imugene
Imugene: Receives key U.S. patent for cancer therapies
Imugene (IMU) shares are trading green today on news the healthcare stock was granted a core U.S. patent
The patent protects Imugene's B-Cell...
Imugene: Signs $5.7M option underwriting agreement
Imugene (IMU) has secured a $5.7 million option underwriting agreement with Bell Potter
The agreement between the company and financial firm relates to...
Imugene: Receives clinical guidance from U.S. FDA for VAXinia
Imugene has received guidance from the U.S. Food and Drug Administration (FDA) for the development of VAXinia
The FDA provided guidance on a...